# Giampiero Girolomoni

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/giampiero-girolomoni/

## Facts

| Field | Value |
| --- | --- |
| Citations | 36,961 |
| Field | Psoriasis: Treatment and Pathogenesis |
| h-index | 99 |
| i10-index | 471 |
| Last Known Institution | University of Verona |
| OpenAlex ID | https://openalex.org/A5016818733 |
| ORCID iD | 0000-0001-8548-0493 |
| Works | 1,380 |

## Researcher papers

Showing 12 of 14.

- [Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I](https://scholariq.org/papers/consensus-based-european-guidelines-for-treatment-of-atopic-eczema-atopic/)
- [Epidemiology of atopic dermatitis in adults: Results from an international survey](https://scholariq.org/papers/epidemiology-of-atopic-dermatitis-in-adults-results-from-an-international-survey/)
- [Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions](https://scholariq.org/papers/psoriasis-and-systemic-inflammatory-diseases-potential-mechanistic-links-between/)
- [European S3‐Guidelines on the systemic treatment of psoriasis vulgaris](https://scholariq.org/papers/european-s3-guidelines-on-the-systemic-treatment-of-psoriasis-vulgaris/)
- [Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II](https://scholariq.org/papers/consensus-based-european-guidelines-for-treatment-of-atopic-eczema-atopic-2/)
- [Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case?control study](https://scholariq.org/papers/prevalence-of-metabolic-syndrome-in-patients-with-psoriasis-a-hospital-based/)
- [Regulatory Activity of Autocrine IL-10 on Dendritic Cell Functions](https://scholariq.org/papers/regulatory-activity-of-autocrine-il-10-on-dendritic-cell-functions/)
- [Patient perspectives in the management of psoriasis: Results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey](https://scholariq.org/papers/patient-perspectives-in-the-management-of-psoriasis-results-from-the-population/)
- [Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate‐to‐severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2)](https://scholariq.org/papers/efficacy-and-safety-of-apremilast-an-oral-phosphodiesterase-4-inhibitor-in/)
- [The Epidermal Growth Factor Receptor System in Skin Repair and Inflammation](https://scholariq.org/papers/the-epidermal-growth-factor-receptor-system-in-skin-repair-and-inflammation/)
- [European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy](https://scholariq.org/papers/european-guideline-euroguiderm-on-atopic-eczema-part-i-systemic-therapy/)
- [European guideline (<scp>EuroGuiDerm</scp>) on atopic eczema – part <scp>II</scp>: non‐systemic treatments and treatment recommendations for special <scp>AE</scp> patient populations](https://scholariq.org/papers/european-guideline-scp-euroguiderm-scp-on-atopic-eczema-part-scp-ii-scp-non/)

## Researcher topics

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Allergic Rhinitis and Sensitization](https://scholariq.org/topics/allergic-rhinitis-and-sensitization/)

## Researcher university

- [University of Verona](https://scholariq.org/institutions/university-of-verona/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.